³ÂÁÁ£¬Ð±¦GGҽѧԺ½ÌÊÚ£¬²©Ê¿Éúµ¼Ê¦£¬º£±íÓÅÇà¡¢ÉϺ£Êк£±í¸ßµµ´ÎÈ˲ţ¬Ð±¦GGΰ³¤Ñ§Õߣ¬¹ú¶ÈÌìÈ»¿Æѧ»ù½ð³Á´óÏîÄ¿¿ÎÌâÕƹÜÈË£¬ÖØÒª×êÑз½Ïò£º1.ϰȾ£¬Ö×Áö£¬×ÔÉíÃâÒßÐÔ¼²²¡ÖеÄTϸ°ûÊÜÌå¼ø±ðÌØÒìÐÔ£»2.ͨ¹ýϵͳÉúÎïѧ²½Öè¼ø¶¨¿¹ÔÌØÒìÐÔTϸ°û£»3.¿ª·¢Õë¶ÔʵÌåÁöµÄTϸ°ûÒ½ÖÎÐÂÕ½Êõ¡£´ú±íÐԳɾͰ䷢ÔÚScience¡¢Signal Transduction and Targeted Therapy¡¢Nature Immunology¡¢Cellular & Molecular Immunology¡¢Hepatology¡¢Journal of ImmunologyµÈ¹ú¼Êҽѧ¼°ÃâÒßѧ¶¥¼¶ÔÓÖ¾¡£
2024Äê1ÔÂ29ÈÕ£¬³ÂÁÁ½ÌÊÚÍŶÓÓë¿Õ¾ü¾üÒ½´óѧµÚÒ»´ÓÊôÒ½ÔºÖìƽ½ÌÊÚÍŶӡ¢»ù´¡Ò½Ñ§ÔºÏ¸°ûÉúÎïѧ½ÌÑÐÊÒ/¹ú¶È·Ö×Óҽѧת»¯ÖÐÐĽ¯½¨Àû×êÑÐÔ±ÍŶӺÏ×÷ÔÚNatureÆìϵÄCellular & Molecular ImmunologyÔÓÖ¾£¨IF£º24.1£©ÉÏ°ä·¢ÁËÌâΪ¡°Id2 epigenetically controls CD8+ T-cell exhaustion by disrupting the assembly of the Tcf3-LSD1 complex¡±µÄ×êÑÐÂÛÎÄ¡£¸Ã×êÑнÒʾÁËId2½éµ¼CD8+ Tϸ°ûºÄ½ßÒÖÔìÖ×ÁöÃâÒßÌÓÒݵÄÐÂÐÍ·Ö×Ó»úÔì¡£
¸Ã×êÑÐͨ¹ý¹¹½¨¶àÖÖ»ùÒò½¨ÊÎÓ×ÊóÄ£ÐÍ£¬´³Õ·ÊÓ¡¢Ï¸°ûºÍ¶¯ÎïÄ£Ð͵ȶà¸ö²ãÃ棬·¢ÏÖId2¿ÉÄÜÍƽøCD8+ Tϸ°û¶ÔÖ×Áöϸ°ûµÄɱÉË£¬µ÷¿ØÔçÆںĽßCD8+ Tϸ°ûÓëÖÕÄ©ºÄ½ßCD8+ Tϸ°ûµÄÐγɣ¬ÒÖÔìÖ×ÁöÃâÒßÌÓÒÝ¡£»úÔì·½Ã棬Id2ÒÖÔìTcf3-LSD1ת¼µ÷¿Ø¸´ºÏÌåµÄ×é×°£¬´Ó¶øÒÖÔì×éµ°°×Àµ°±ËáÌØÒìÐÔÈ¥¼×»ù»¯Ã¸LSD1¶ÔTϸ°ûºÄ½ß¹Ø¼ü»ùÒòSlamf6ÓйØȾɫÖÊ×éµ°°×H3K4me2È¥½¨ÊΣ¬³ÁËÜCD8+ Tϸ°ûµÄȾɫÖÊÊ¢¿ªÐÔ¡£±¾×êÑгõ´Î±¨Â·ÁËId2×÷ΪÃâÒßϵͳ±í¹ÛÒÅ´«µ÷¿ØÒò×Ó£¬¼ÓÇ¿CD8+ Tϸ°û¿¹Ö×ÁöÃâÒßÓ¦´ð£¬ÒÖÔìÖ×ÁöÃâÒßÌÓÒÝ¡£
³Á´ó¼²²¡ÐÂÒ©°Ð·¢ÏÖ¼°ÐÂÒ©´´ÔìÈ«¹ú³Áµã³¢ÊÔÊÒ¼ò½é
2023Äê3Ô£¬¸ÓÄÏ´´ÐÂÓëת»¯Ò½Ñ§×êÑÐÔº¡¢¿Õ¾ü¾üÒ½´óѧ¡¢½Î÷Çà·åÒ©ÒµÈý·½½áºÏ¹²½¨µÄÐÂÒ©´´ÔìÈ«¹ú³Áµã³¢ÊÔÊÒ»ñµÃ¿Æ¼¼²¿ºË×¼½¨Éè¡£¸Ã³¢ÊÔÊÒÖØÒª×êÑз½ÏòΪÐÄѪ¹Ü¼²²¡¡¢´úлÐÔ¼²²¡¡¢Ö×ÁöµÈ³Á´ó¼²²¡´´Ð¿¹ÌåÒ©ÎïÓë·Ö×ÓÒ½Ò©¿ª·¢£¬ÖØÒª½â¾öÎÒ¹úÐÂÒ©´´ÔìµÄÔʼ´´ÐÂÄÜÁ¦²»¼°¡¢¸ß¸½¼ÓÖµ²úÆ·¹ú¼Ê¾ºÕùÁ¦µÍ¡¢´´ÐÂÁ´ºÍ²úÒµÁ´ÏµÍ³ÍѽڵȳÁ´ó¿Æ¼¼ÎÊÌ⣬´òÔìÖ§³ÖºÍÒýÁìÎÒ¹úÈËÀà³Á´ó¼²²¡·Ö×Ó¿ÆѧÓëת»¯×êÑм°ÐÂÒ©´´ÔìµÄÖ÷Ìâ»ùµØºÍƽ̨£¬ÊµÏÖ¹ú¼ÊÒ»Á÷µÄÉúÎïÒ½Ò©³Á´óÔʼ´´Ðºͼ¼ÊõÍ»ÆÆ£¬ÐγÉÎÒ¹úÉúÎïÒ½Ò©ÁìÓò³ÁÒªÕ½ÊõÁ¦Á¿¡£
